Holen Sie sich die Stockscreener-App
12.39
1.90%
-0.24
Schlusskurs vom Vortag:
$12.63
Offen:
$12.55
24-Stunden-Volumen:
1.51M
Relative Volume:
0.99
Marktkapitalisierung:
$699.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-72.89M
KGV:
-5.1198
EPS:
-2.42
Netto-Cashflow:
$-68.47M
1W Leistung:
-1.20%
1M Leistung:
+64.76%
6M Leistung:
+131.16%
1J Leistung:
+9.45%
1-Tages-Spanne:
$12.34
$12.64
1-Wochen-Bereich:
$12.34
$12.71
52-Wochen-Spanne:
$3.555
$12.71
Astria Therapeutics Inc Stock (ATXS) Company Profile
Firmenname
Astria Therapeutics Inc
Sektor
Branche
Telefon
617-349-1971
Adresse
22 BOSTON WHARF ROAD, BOSTON
Vergleichen Sie ATXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
12.39 | 712.77M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-17 | Bestätigt | H.C. Wainwright | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-31 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | TD Cowen | Buy |
| 2023-03-28 | Eingeleitet | Evercore ISI | Outperform |
Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten
Is this a good reentry point in Astria Therapeutics Inc.Weekly Gains Report & Expert Approved Trade Ideas - newser.com
Can Astria Therapeutics Inc. stock maintain operating marginsCEO Change & Growth Oriented Trading Recommendations - newser.com
Will Astria Therapeutics Inc. stock deliver shareholder valueMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Will Astria Therapeutics Inc. stock maintain dividend yieldLong Setup & Entry Point Confirmation Signals - newser.com
Is Astria Therapeutics Inc. stock attractive for income investorsJuly 2025 Closing Moves & Momentum Based Trading Signals - newser.com
Why Astria Therapeutics Inc. is moving today2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
Will Astria Therapeutics Inc. stock split again soonForecast Cut & Daily Risk Controlled Trade Plans - newser.com
Chart overlay techniques for tracking Astria Therapeutics Inc.Quarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Why Astria Therapeutics Inc. stock is in analyst buy zone2025 Momentum Check & High Accuracy Swing Trade Signals - newser.com
What moving averages say about Astria Therapeutics Inc.July 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Can Astria Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Using R and stats models for Astria Therapeutics Inc. forecasting2025 Market Overview & Precise Swing Trade Entry Alerts - newser.com
Will Astria Therapeutics Inc. stock reach Wall Street targetsQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Evaluating Astria Therapeutics Inc. with trendline analysis2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Is Astria Therapeutics Inc. stock a contrarian buyMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Multi factor analysis applied to Astria Therapeutics Inc.2025 Biggest Moves & Fast Moving Market Watchlists - newser.com
Applying big data sentiment scoring on Astria Therapeutics Inc.Portfolio Performance Report & Safe Capital Growth Plans - newser.com
Will Astria Therapeutics Inc. stock beat EPS estimatesWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Strategies to average down on Astria Therapeutics Inc.2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
Intraday pattern recognizer results for Astria Therapeutics Inc.Buy Signal & Technical Pattern Based Signals - newser.com
Astria Therapeutics (ATXS) Price Target Decreased by 13.25% to 26.35 - MSN
Is Astria Therapeutics Inc. stock overvalued by current metricsEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Astria Therapeutics, Inc.Common Stock (NQ: ATXS - FinancialContent
Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors - Barron's
Astria Therapeutics (NASDAQ:ATXS) Hits New 1-Year HighHere's Why - MarketBeat
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - Business Wire
Institutional scanner results for Astria Therapeutics Inc.2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
What MACD and RSI say about Astria Therapeutics Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Is Astria Therapeutics Inc. trending in predictive chart modelsMarket Rally & Free Safe Capital Growth Stock Tips - newser.com
Combining price and volume data for Astria Therapeutics Inc.Portfolio Value Summary & Low Drawdown Investment Ideas - newser.com
Magnetar Financial LLC's Strategic Acquisition of Astria Therape - GuruFocus
Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):